BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38583885)

  • 21. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors.
    Wang Z; Yan J; Hu W; Zhang J; Huo B
    Neoplasma; 2018; 65(4):592-598. PubMed ID: 29940758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
    Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
    BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
    Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
    Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
    Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H
    World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
    Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
    [No Abstract]   [Full Text] [Related]  

  • 29. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
    Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
    Zhang Y; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis.
    Matsunaga T; Ishiguro R; Miyauchi W; Shishido Y; Miyatani K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    BMC Surg; 2021 Jan; 21(1):33. PubMed ID: 33422067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E; Celen O; Berberoglu U
    J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination of preoperative fibrinogen-to-albumin ratio and postoperative TNM stage (FAR-TNM) predicts the survival in gastric cancer patients after gastrectomy.
    Zhang X; Qiu X; Yin H; Zhao W; Song L; Zhang X; Yang L; Tao M
    Biomarkers; 2023 Dec; 28(8):714-721. PubMed ID: 38059615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.